Cuddling Up to BDSI

Triangle Business Journal – As BioDelivery Sciences International awaits approval of its first product, a New York hedge fund has gained control of enough BDSI shares to become its largest shareholder.

With what looks like one goal in mind – making a lot of money.

Elliott International Capital Advisors is the same firm that tried to shake up Raleigh-based BDSI with a management change two years ago. That was at a time when the company was developing Onsolis, a small disk placed on the inside of the cheek that quickly delivers the drug fentanyl to cancer patients suffering breakthrough pain.

Read Complete Article

About the HedgeCo News Team

The Hedge Fund News Team stays on top of breaking news in the Hedge Fund industry on an hourly basis. Signup to HedgeCo.Net to recieve Daily or Weekly news updates from our team.
This entry was posted in Syndicated and tagged , , , , , , , , , , , , . Bookmark the permalink.

Comments are closed.